Legault, K;
Schunemann, H;
Hillis, C;
Yeung, C;
Akl, E. A;
Carrier, M;
Cervera, R;
Crowther, M;
Dentali, F;
Erkan, D;
Espinosa, G;
Khamashta, M;
Meerpohl, J. J;
Moffat, K;
O'Brien, S;
Pengo, V;
Rand, J. H;
Rodriguez Pinto, I;
Thom, L;
Iorio, A.
Background The McMaster RARE-Bestpractices project group selected the catastrophic antiphospholipid syndrome (CAPS) for a pilot exercise in guideline development for a rare disease. Objectives The objectives of this exercise were to provide a proof of principle that guidelines can be developed for rare d...
Al-Hameed, F. M;
Al-Dorzi, H. M;
Abdelaal, M. A;
Alaklabi, A;
Bakhsh, E;
Alomi, Y. A;
Al Baik, M;
Aldahan, S;
Schünemann, H;
Brozek, J;
Wiercioch, W;
Darzi, A. J;
Waziry, R;
Akl, E. A.
Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a preventable disease. Long distant travelers are prone to variable degree to develop VTE. However, the low risk of developing VTE among long-distance travelers and which travelers should receive VTE prophy...
Darzi, A;
Harfouche, M;
Arayssi, T;
Alemadi, S;
Alnaqbi, K. A;
Badsha, H;
Al Balushi, F;
Elzorkany, B;
Halabi, H;
Hamoudeh, M;
Hazer, W;
Masri, B;
Omair, M. A;
Uthman, I;
Ziade, N;
Singh, J. A;
Christiansen, R;
Tugwell, P;
Schünemann, H. J;
Akl, E. A.
BACKGROUND: It has been hypothesized that adaptation of health practice guidelines to the local setting is expected to improve their uptake and implementation while cutting on required resources. We recently adapted the published American College of Rheumatology (ACR) Rheumatoid Arthritis (RA) treatment ...
Busse, J. W;
Craigie, S;
Juurlink, D. N;
Buckley, D. N;
Wang, L;
Couban, R. J;
Agoritsas, T;
Akl, E. A;
Carrasco-Labra, A;
Cooper, L;
Cull, C;
Costa, B. R. da;
Frank, J. W;
Grant, G;
Iorio, A;
Persaud, N;
Stern, S;
Tugwell, P;
Vandvik, P. O;
Guyatt, G. H.
Guideline for opioid therapy and chronic noncancer pain: the objective is to inform the prescribing of opioids for adults with chronic noncancer pain....
Ward, M. M;
Deodhar, A;
Akl, E. A;
Lui, A;
Ermann, J;
Gensler, L. S;
Smith, J. A;
Borenstein, D;
Hiratzka, J;
Weiss, P. F;
Inman, R. D;
Majithia, V;
Haroon, N;
Maksymowych, W. P;
Joyce, J;
Clark, B. M;
Colbert, R. A;
Figgie, M. P;
Hallegua, D. S;
Prete, P. E;
Rosenbaum, J. T;
Stebulis, J. A;
Bosch, F van den;
Yu, D. T;
Miller, A. S;
Reveille, J. D;
Caplan, L.
OBJECTIVE: To provide evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). METHODS: A core group led the development of the recommendations, starting with the treatment questions. A literature review group conduct...
Espondilitis Anquilosante/tratamiento farmacológico,
Espondiloartritis/tratamiento farmacológico,
Antiinflamatorios no Esteroideos/uso terapéutico,
Antirreumáticos/uso terapéutico,
Glucocorticoides/uso terapéutico,
Factor de Necrosis Tumoral alfa/uso terapéutico,
Infliximab/uso terapéutico,
Adalimumab/uso terapéutico,
Etanercept/uso terapéutico,
Modalidades de Fisioterapia,
Espondilitis Anquilosante/terapia
Singh, J. A;
Saag, K. G;
Bridges Junior, S. L;
Akl, E. A;
Bannuru, R. R;
Sullivan, M. C;
Vaysbrot, E;
McNaughton, C;
Osani, M;
Shmerling, R. H;
Curtis, J. R;
Furst, D. E;
Parks, D;
Kavanaugh, A;
O'Dell, J;
King, C;
Leong, A;
Matteson, E. L;
Schousboe, J. T;
Drevlow, B;
Ginsberg, S;
Grober, J;
St Clair, E. W;
Tindall, E;
Miller, A. S;
McAlindon, T.
OBJECTIVE: To develop a new evidence-based, pharmacologic treatment guideline for rheumatoid arthritis (RA). METHODS: We conducted systematic reviews to synthesize the evidence for the benefits and harms of various treatment options. We used the Grading of Recommendations Assessment, Development and Eval...
Al-Hameed, F. M;
Al-Dorzi, H. M;
Abdelaal, M. A;
Alaklabi, A;
Bakhsh, E;
Alomi, Y. A;
Al Baik, M;
Aldahan, S;
Schünemann, H;
Brozek, J;
Wiercioch, W;
Darzi, A. J;
Waziry, R;
Akl, E. A.
Venous thromboembolism (VTE) acquired during hospitalization is common, yet preventable by the proper implementation of thromboprophylaxis which remains to be underutilized worldwide. As a result of an initiative by the Saudi Ministry of Health to improve medical practices in the country, an expert panel...
Al-Hameed, F;
Al-Dorzi, H. M;
AlMomen, A;
Algahtani, F;
AlZahrani, H;
AlSaleh, K;
AlSheef, M;
Owaidah, T;
Alhazzani, W;
Neumann, I;
Wiercioch, W;
Brozek, J;
Schünemann, H;
Akl, E. A.
BACKGROUND AND OBJECTIVES: Venous thromboembolism (VTE) is commonly encountered in the daily clinical practice. Cancer is an important VTE risk factor. Proper thromboprophylaxis is key to prevent VTE in patients with cancer, and proper treatment is essential to reduce VTE complications and adverse events...
Al-Hameed, F. M;
Al-Dorzi, H. M;
Al-Momen, A. M;
Algahtani, F. H;
Al-Zahrani, H. A;
Al-Saleh, K. A;
Al-Sheef, M. A;
Owaidah, T. M;
Alhazzani, W;
Neumann, I;
Wiercioch, W;
Brozek, J;
Schunemann, H;
Akl, E. A.
Venous thromboembolism (VTE) including deep vein thrombosis (DVT) and pulmonary embolism (PE) is commonly encountered in daily clinical practice. After diagnosis, its management frequently carries significant challenges to the clinical practitioner. Treatment of VTE with the inappropriate modality and/or...
Chest; 141 (2,supl), 2012
The Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines differs substantially from the prior versions both in process and in content. In this introduction, we describe some of the differences and the rationale for t...
